Nov 07 2024
GoodRx Reports Third Quarter 2024 Results

SANTA MONICA, Calif. --(BUSINESS WIRE)--Nov. 7, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S. , has released its financial results for the third quarter of 2024.

PDF Version
Nov 04 2024
GoodRx to Participate in Upcoming Investor Conferences
SANTA MONICA, Calif. --(BUSINESS WIRE)--Nov. 4, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S. , today announced that executives from the Company will participate in a fireside chat at each of the following investor
PDF Version
Oct 28 2024
Ronald E. Bruehlman Joins GoodRx Board of Directors
IQVIA CFO brings 39 years of healthcare and finance expertise to GoodRx SANTA MONICA, Calif. --(BUSINESS WIRE)--Oct. 28, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S.
PDF Version
Aug 21 2024
GoodRx to Participate in Upcoming Investor Conferences
SANTA MONICA, Calif. --(BUSINESS WIRE)--Aug. 21, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S. , today announced that executives from the Company will participate in a fireside chat at each of the following investor
PDF Version
Displaying 1 - 10 of 30